Literature DB >> 3058070

Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Review.

M A Sirgo1, R J Mills, V DeQuattro.   

Abstract

Blood pressure and heart rate exhibit a circadian rhythm, with both rising rapidly during the morning hours and then decreasing throughout the day to a nadir around 3 AM. Current evidence suggests a possible link between cardiovascular events, such as myocardial infarction and sudden cardiac death, which have been shown to occur most frequently during the morning hours, and the rapid rise in blood pressure and heart rate during this same time period. We review data from ambulatory blood pressure studies to ascertain which antihypertensive agents provide the most satisfactory control of blood pressure and heart rate during the hours of 6 AM to 12 noon. Of the forms of drug therapy studied, labetalol, a combined alpha- and beta-blocker, and two calcium channel blockers, nifedipine and verapamil, appear to be the most effective in blunting the rise in arterial blood pressure during these critical morning hours.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058070

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials.

Authors:  P E Pool; J M Nappi; M A Weber
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Diurnal variation of essential and physiological tremor.

Authors:  J J van Hilten; J G van Dijk; R J Dunnewold; E A van der Velde; B Kemp; P van Brummelen; J A van der Krogt; R A Roos; O J Buruma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

Review 3.  Lowering blood pressure. How far, how fast?

Authors:  A Roca-Cusachs
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  [Morning rise in blood pressure: before or following awakening?].

Authors:  P Baumgart; K H Rahn
Journal:  Klin Wochenschr       Date:  1990-03-16

Review 5.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

6.  Statistical evaluation of circadian blood pressure rhythm during isradipine long-term therapy.

Authors:  F Veglio; F Rabbia; R Melchio; L Chiandussi
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.

Authors:  T D Ruddy; J M Wright; D Savard; S P Handa; A Chockalingam; L Fischer; A P Boulet
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

8.  Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.

Authors:  L M Ruilope; M C Casal; L Guerrero; J M Alcázar; M L Férnandez; V Lahera; J L Rodicio
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.

Authors:  T Tsuchihashi; A Tsukashima; K Matsumura; I Abe; M Tominaga; Y Nakao; K Kobayashi; M Fujishima
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Predictors of mean arterial pressure morning rate of rise and power function in subjects undergoing ambulatory blood pressure recording.

Authors:  Geoffrey A Head; Nick Andrianopoulos; Barry P McGrath; Catherine A Martin; Melinda J Carrington; Elena V Lukoshkova; Pamela J Davern; Garry L Jennings; Christopher M Reid
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.